SLC35A2 and Hyperbilirubinemia: Breastfeeding has been recognized as a contributing factor for the development of neonatal hyperbilirubinemia, as the breastmilk of some women contains a metabolite of progesterone called 3α,20β-pregnanediol, which inhibits UDP-glucuronosyltransferase (UGT) bilirubin glucuronidation activity [4].